Factors that may influence the experience of hot flushes by healthy middle-aged women

Journal of Women's Health

Volumn 19, Issue 10, 2010, Pages 1905-1914

  Ziv Gal, Ayelet ^a   Flaws, Jodi A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; AROMATASE; CIGARETTE SMOKE; ESTRADIOL; ESTRONE; FOLLITROPIN; INHIBIN A; INHIBIN B; ISOFLAVONE; LIOTHYRONINE; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PHYTOESTROGEN; PRASTERONE SULFATE; SEX HORMONE BINDING PROTEIN; TESTOSTERONE; THYROTROPIN; THYROXINE;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CIGARETTE SMOKING; DEPRESSION; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; ETHNICITY; GENETIC POLYMORPHISM; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HOT FLUSH; HUMAN; MEDLINE; MENOPAUSE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RACE; SCIENTIFIC LITERATURE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; VASOMOTOR DISORDER;

ALCOHOL DRINKING; FEMALE; GONADAL STEROID HORMONES; HEALTH STATUS; HOT FLASHES; HUMANS; MENOPAUSE; MOOD DISORDERS; POLYMORPHISM, GENETIC; SMOKING; WOMEN'S HEALTH;

EID: 77957975198     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1852     Document Type: Article

References (111)

1. Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: A review. Can J Physiol Pharmacol 1987;65:1312-1324.
2. Andrikoula M, Prelevic G. Menopausal hot flushes revisited. Climacteric 2009;12:3-15.
3. Sturdee DW. The menopausal hot flush-Anything new? Maturitas 2008;60:42-49.
4. Deecher DC. Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opinion Investig Drugs 2005;14: 435-448.
5. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet 2002;360:1851-1861.
6. Simpkins JW, Brown K, Bae S, Ratka A. Role of ethnicity in the expression of features of hot flashes. Maturitas 2009; 63:341-346.
7. Hahn PM, Wong J, Reid RL. Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril 1998; 70:913-918.
8. Xu J, Bartoces M, Neale AV, Dailey RK, Northrup J, Schwartz KL. Natural history of menopause symptoms in primary care patients: A MetroNet study. J Am Board Fam Pract 2005;18:374-382.
9. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 2007; 10:247-257.
10. Ho SC, Gaen CS, Bing YY, Yee CS, Sham A. Factors associated with menopausal symptom reporting in Chinese midlife women. Maturitas 2003;44:149-156.
11. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96:1226-1235.
12. Freeman EW, Sammel MD, Lin H, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110: 230-240.
13. Dennerstein L, Lehert P, Guthrie JR, Burger HG. Modeling women's health during the menopausal transition: A longitudinal analysis. Menopause 2007;14:53-62.
14. Burger H, Woods NF, Dennerstein L, Alexander JL, Kotz K, Richardson G. Nomenclature and endocrinology of menopause and perimenopause. Expert Rev Neurother 2007;7: S35-S43.
15. Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by women in midlife: Menopausal transition or aging? Menopause 2009;16:1021-1029.
16. Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 2008;11:32-43.
17. Loh FH, Khin LW, Saw SM, Lee JJ, Gu K. The age of menopause and the menopause transition in a multiracial population: A nation-wide Singapore study. Maturitas 2005;52:169-180.
18. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
19. Avis NE, Brockwell S, Colvin A. A universal menopausal syndrome? Am J Med 2005;118:37-46.
20. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multiracial/ ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
21. Hardy R, Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 2002;55:1975-1988.
22. Fuh JL, Wang SJ, Lu SR, Juang KD, Chiu LM. The Kinmen Women-Health Investigation (KIWI): A menopausal study of a population aged 40-54. Maturitas 2001;39:117-124.
23. Hyde Riley E, Inui TS, Kleinman K, Connelly MT. Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women. J Gen Intern Med 2004;19:740-746.
24. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes 2005;3:47.
25. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004:CD002978.
26. Schilling C, Gallicchio L, Miller SR, Langenberg P, Zacur H, Flaws JA. Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas 2007;57:120-131. (Pubitemid 46771023)
27. Miller SR, Gallicchio LM, Lewis LM, et al. Association between race and hot flashes in midlife women. Maturitas 2006;54:260-269.
28. Fentiman IS, Allen D, Wheeler M, Rymer J. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT. Climacteric 2006;9:135-145.
29. Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA. Risk factors for hot flashes in midlife women. J Womens Health 2003;12:459-472.
30. Woods NF, Carr MC, Tao EY, Taylor HJ, Mitchell ES. Increased urinary cortisol levels during the menopausal transition. Menopause 2006;13:212-221.
31. Longcope C. Endocrine function of the postmenopausal ovary. J Soc Gynecol Investig 2001;8:S67-S68.
32. Burger H. The menopausal transition-Endocrinology. J Sex Med 2008;5:2266-2273.
33. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 2007;92:3040-3043. (Pubitemid 47236368)
34. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90:3847-3853.
35. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87:3760-3767.
36. Overlie I, Morkrid L, Andersson AM, Skakkebaek NE, Moen MH, Holte A. Inhibin A and B as markers of menopause: A five-year prospective longitudinal study of hormonal changes during the menopausal transition. Acta Obstet Gynecol Scand 2005;84:281-285.
37. Sammel MD, Freeman EW, Liu Z, Lin H, Guo W. Factors that influence entry into stages of the menopausal transition. Menopause 2009;16:1218-1227.
38. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009;16:728-734.
39. Casper RF, Yen SS. Menopausal flushes: Effect of pituitary gonadotropin desensitization by a potent luteinizing hormone-releasing factor agonist. J Clin Endocrinol Metab 1981;53:1056-1058.
40. Hale GE, Burger HG. Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Pract Res Clin Obstet Gynaecol 2009;23:7-23.
41. Sowers M, Luborsky J, Perdue C, Araujo KL, Goldman MB, Harlow SD. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the midlife: SWAN. Clin Endocrinol (Oxf ) 2003;58:340-347.
42. Rojas LV, Nieves K, Suarez E, OrtizAP, Rivera A, Romaguera J. Thyroid-stimulating hormone and follicle-stimulating hormone status in Hispanic women during the menopause transition. Ethn Dis 2008;18:S2-S4.
43. Badawy A, State O, Sherief S. Can thyroid dysfunction explicate severe menopausal symptoms? J Obstet Gynecol 2007;27:503-505.
44. Malacara JM, Perez-Luque EL, Martinez-Garza S, Sanchez- Marin FJ. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in postmenopausal women. Maturitas 2004;49:163-169.
45. Crandall CJ, Crawford SL, Gold EB. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 2006;119:S52-S60.
46. Sowers MR, Jannausch ML, McConnell DS, Kardia SR, Randolph JF Jr. Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes. Am J Med 2006;119: S31-S43.
47. Takeo C, Negishi E, Nakajima A, et al. Association of cytosineadenine repeat polymorphism of the estrogen receptorbeta gene with menopausal symptoms. Gend Med 2005;2: 96-105.
48. Massad-Costa AM, Nogueira-de-Souza NC, de Carvalho CV, et al. CYP17 polymorphism and hot flushes in postmenopausal women. Climacteric 2008;11:404-408.
49. Visvanathan K, Gallicchio L, Schilling C, et al. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 2005;106:1372-1381.
50. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:1521-1527.
51. Woods NF, Mitchell ES, Tao Y, Viernes HM, Stapleton PL, Farin FM. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: Observations from the Seattle Midlife Women's Health Study. Menopause 2006;13:902-910.
52. Freeman EW, Sammel MD, Grisso JA, Battistini M, Garcia- Espagna B, Hollander L. Hot flashes in the late reproductive years: Risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 2001;10:67-76.
53. Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2001;8:33-42. (Pubitemid 32066578)
54. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189-1199.
55. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: A systematic review. Climacteric 2007;10:197-214.
56. Brown DE, Sievert LL, Morrison LA, Reza AM, Mills PS. Do Japanese American women really have fewer hot flashes than European Americans? The Hilo Women's Health Study. Menopause 2009;16:870-876.
57. Ishizuka B, Kudo Y, Tango T. Cross-sectional community survey of menopause symptoms among Japanese women. Maturitas 2008;61:260-267.
58. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: The Japanese case. Maturitas 1988; 10:317-332.
59. Melby MK. Vasomotor symptom prevalence and language of menopause in Japan. Menopause 2005;12:250-257.
60. Schnatz PF, Serra J, O'Sullivan DM, Sorosky JI. Menopausal symptoms in Hispanic women and the role of socioeconomic factors. Obstet Gynecol Surv 2006;61:187-193.
61. Anderson GS. Human morphology and temperature regulation. Int J Biometeorol 1999;43:99-109.
62. Haymes EM, McCormick RJ, Buskirk ER. Heat tolerance of exercising lean and obese prepubertal boys. J Appl Physiol 1975;39:457-461.
63. Thurston RC, Sowers MR, Chang Y, et al. Adiposity and reporting of vasomotor symptoms among midlife women: The Study of Women's Health Across the Nation. Am J Epidemiol 2008;167:78-85.
64. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Womens Health 1998;7: 1149-1155.
65. Gallicchio L, Visvanathan K, Miller SR, et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 2005;193:1353-1360.
66. Schilling C, Gallicchio L, Miller SR, Langenberg P, Zacur H, Flaws JA. Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women. Climacteric 2007;10:27-37.
67. Kumari M, Stafford M, Marmot M. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms. J Clin Epidemiol 2005;58:719-727.
68. Ford K, Sowers M, Crutchfield M, Wilson A, Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 2005;12:308-317.
69. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434.
70. Joffe H, Soares CN, Thurston RC, White DP, Cohen LS, Hall JE. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause 2009;16:671-679.
71. Brown JP, Gallicchio L, Flaws JA, Tracy JK. Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas 2009;62:184-189.
72. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006;63:385-390.
73. Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-398.
74. Ozturk O, Eraslan D, Mete HE, Ozsener S. The risk factors and symptomatology of perimenopausal depression. Maturitas 2006;55:180-186.
75. Woods NF, Smith-Dijulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: Observations from the Seattle Midlife Women's Health Study. Menopause 2008; 15:223-232.
76. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4: 243-249.
77. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-266.
78. Thurston RC, Joffe H, Soares CN, Harlow BL. Physical activity and risk of vasomotor symptoms in women with and without a history of depression: Results from the Harvard Study of Moods and Cycles. Menopause 2006; 13:553-560.
79. Thurston RC, Bromberger J, Chang Y, et al. Childhood abuse or neglect is associated with increased vasomotor symptom reporting among midlife women. Menopause 2008;15:16-22.
80. Park MK, Satoh N, Kumashiro M. Mental workload under time pressure can trigger frequent hot flashes in menopausal women. Ind Health 2008;46:261-268.
81. Greendale GA, Gold EB. Lifestyle factors: Are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118:148-154.
82. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305-1309.
83. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162:502-514.
84. Mattison DR. The mechanisms of action of reproductive toxins. Am J Ind Med 1983;4:65-79.
85. Bengtsson M, Montelius J, Mankowitz L, Rydstrom J. Metabolism of polycyclic aromatic hydrocarbons in the rat ovary. Comparison with metabolism in adrenal and liver tissues. Biochem Pharmacol 1983;32:129-136.
86. Lutterodt MC, Sorensen KP, Larsen KB, Skouby SO, Andersen CY, Byskov AG. The number of oogonia and somatic cells in the human female embryo and fetus in relation to whether or not exposed to maternal cigarette smoking. Hum Reprod 2009;24:2558-2566.
87. Tuttle AM, Stampfli M, Foster WG. Cigarette smoke causes follicle loss in mice ovaries at concentrations representative of human exposure. Hum Reprod 2009;24: 1452-1459.
88. Schwingl PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot flashes. Obstet Gynecol 1994;84:29-34.
89. Longcope C, Johnston CC Jr. Androgen and estrogen dynamics in pre- and postmenopausal women: A comparison between smokers and nonsmokers. J Clin Endocrinol Metab 1988;67:379-383.
90. Gallicchio L, Miller SR, Visvanathan K, et al. Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas 2006;53:133-143. (Pubitemid 41820506)
91. Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA. Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol 2008;112:1037-1044.
92. Sievert LL, Morrison L, Brown DE, Reza AM. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause 2007;14:261-269.
93. Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Managed Care Pharm 2008;14:14-19.
94. Song WO, Chun OK, Hwang I, et al. Soy isoflavones as safe functional ingredients. J Med Food 2007;10:571-580.
95. D'Anna R, Cannata ML, Marini H, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: A 2-year randomized, double-blind, placebo-controlled study. Menopause 2009;16:301-306.
96. Kronenberg F. Hot flashes: Epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86.
97. Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: Relationship to the literature. Alcohol Clin Exp Res 1992; 16:87-92.
98. Gavaler JS. Alcohol effects on hormone levels in normal postmenopausal women and in postmenopausal women with alcohol-induced cirrhosis. Recent Dev Alcohol 1995; 12:199-208.
99. Gavaler JS. Alcoholic beverages as a source of estrogens. Alcohol Health Res World 1998;22:220-227.
100. Gavaler JS, Deal SR, Van Thiel DH, Arria A, Allan MJ. Alcohol and estrogen levels in postmenopausal women: The spectrum of effect. Alcohol Clin Exp Res 1993;17:786-790.
101. Schilling C, Gallicchio L, Miller SR, et al. Current alcohol use is associated with a reduced risk of hot flashes in midlife women. Alcohol Alcohol 2005;40:563-568.
102. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29:139-146.
103. Li S, Holm K. Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women. West J Nurs Res 2003; 25:274-288.
104. Whitcomb BW, Whiteman MK, Langenberg P, Flaws JA, Romani WA. Physical activity and risk of hot flashes among women in midlife. J Womens Health 2007;16: 124-133.
105. Kemmler W, von Stengel S, Weineck J, Lauber D, Kalender W, Engelke K. Exercise effects on menopausal risk factors of early postmenopausal women: 3-yr Erlangen Fitness Osteoporosis Prevention Study results. Med Sci Sports Exerc 2005;37:194-203.
106. Romani WA, Gallicchio L, Flaws JA. The association between physical activity and hot flash severity, frequency, and duration in mid-life women. Am J Hum Biol 2009; 21:127-129.
107. Di Donato P, Giulini NA, Bacchi MA, et al. Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas 2005;52:181-189.
108. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990;69:409-412.
109. Guthrie JR, Smith AM, Dennerstein L, Morse C. Physical activity and the menopause experience: A cross-sectional study. Maturitas 1994;20:71-80.
110. Albertson AJ, Skinner DC. A novel animal model to study hot flashes: No effect of gonadotropin-releasing hormone. Menopause 2009;16:1030-1036.
111. Freedman RR, Wasson S. Miniature hygrometric hot flash recorder. Fertil Steril 2007;88:494-496.